Xerardo García-Mera Selected Research

Xerardo García-Mera Research Topics

5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 12/2011
3	Neoplasms (Cancer) 03/2024 - 01/2021
2	Neuroblastoma 01/2024 - 10/2021
2	Amyloid Plaque 01/2012 - 12/2011
2	Alzheimer Disease (Alzheimer's Disease) 01/2012 - 12/2011
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Dyskinesias (Dyskinesia) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Cognitive Dysfunction 01/2012
1	Dementia (Dementias) 01/2012
1	Memory Disorders (Memory Loss) 12/2011
1	Nervous System Diseases (Neurological Disorders) 11/2011
1	Leukemia 01/2009

4	Peptides (Polypeptides)IBA 01/2024 - 12/2011
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2024 - 12/2023
2	Immune Checkpoint InhibitorsIBA 03/2024 - 12/2023
2	Neuroprotective AgentsIBA 01/2024 - 04/2013
2	TOPSIBA 04/2013 - 01/2009
2	Amyloid (Amyloid Fibrils)IBA 01/2012 - 12/2011
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 11/2011
1	Complement System Proteins (Complement)IBA 03/2024
1	Antineoplastic Agents (Antineoplastics)IBA 03/2024
1	Proline (L-Proline)FDA Link 01/2024
1	prolylglutamic acidIBA 01/2023
1	glycyl-prolyl-glutamic acidIBA 01/2023
1	Oxidopamine (6 Hydroxydopamine)IBA 10/2021
1	CytochromesIBA 01/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021
1	Cytochrome P-450 CYP3AIBA 01/2021
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2021
1	AcetylcholinesteraseIBA 01/2012
1	Glycogen Synthase (Synthase I)IBA 11/2011

5	Therapeutics 03/2024 - 01/2012
1	Immunotherapy 03/2024